Last updated: 11/07/2018 13:53:48
A Double-Blind, Placebo-Controlled, Continuation of Study 29060/120 to Assess the Long Term Safety and Efficacy of Paroxetine in the Treatment of Panic Disorder and its Role in the Prevention of Relapse/Recurrence
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Double-Blind, Placebo-Controlled, Continuation of Study 29060/120 to Assess the Long Term Safety and Efficacy of Paroxetine in the Treatment of Panic Disorder and its Role in the Prevention of Relapse/Recurrence
Trial description: A Double-Blind, Placebo-Controlled, Continuation of Study 29060/120 to Assess the Long Term Safety and Efficacy of Paroxetine in the Treatment of Panic Disorder and its Role in the Prevention of Relapse/Recurrence
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Efficacy and safety of paroxetine in panic disorder. Judge, R 10th World Congress of Psychiatry 8/23/1996 Madrid; Spain
Efficacy and safety of paroxetine in panic disorder. Judge, R 20th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP '96) 6/23/1996 Melbourne; Australia
Efficacy and safety of paroxetine in panic disorder. Judge, R 8th Congress of the Association of European Psychiatrists/Annual Meeting of the Royal College of Psychiatrists 7/7/1996 London; UK
Judge R et al. Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: a double-blind study. Eur. Psychiatry 1996; 11(Suppl 4):346S
Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: a double-blind study. Judge, R, Burnham, D, Steiner, M, Gergel, I, Oakes, R, and Bailer, D 10th World Congress of Psychiatry 8/23/1996 Madrid; Spain
Paroxetine long-term safety and efficay in panic disorder and prevention of relapse: a double-blind study. Judge, R, Burnham, D, Steiner, M, Gergel, I, Oakes, R, Bailer, D, and Wheadon, D 8th Congress of the Association of European Psychiatrists/Annual Meeting of the Royal College of Psychiatrists 7/7/1996 London; UK
The long-term efficacy and safety of paroxetine in panic disorder. Judge, R and Steiner, M 20th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP '96) 6/23/1996 Melbourne; Australia
Medical condition
Panic Disorder
Product
paroxetine
Collaborators
Not applicable
Study date(s)
December 1992 to September 1994
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1994-16-09
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website